Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ImmuneIntelligence AB
AB
Active
Org 5591159776
Korsåkersvägen 53, 226 50
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ImmuneIntelligence AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2020
2M
2021
1M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 230
2 067
1 259
100
100
Staff expenses
—
—
—
—
—
EBITDA
475
934
83
−25
−44
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
475
934
83
−25
−44
Net financials
−1
−3
−6
34
27
Profit before tax
475
931
78
8
−17
Tax
−103
−193
−16
−1
−0
Net profit
372
738
62
7
−17
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 628
2 715
2 531
1 963
1 820
Equity
1 065
1 803
1 865
1 272
1 055
Long-term debt
0
0
0
0
0
Short-term debt
563
912
667
691
765
Total debt
563
912
667
691
765
Financial ratios
5-year trend
EBITDA-margin
-44.0%
This company
15.8%
Market median
-378% vs market
2020
2024
Soliditetsgrad
58.0%
This company
38.2%
Market median
+52% vs market
2020
2024
Egenkapitalforrentning
-1.6%
This company
18.4%
Market median
-109% vs market
2020
2024
Nettoresultatgrad
-17.0%
This company
8.1%
Market median
-310% vs market
2020
2024
Aktivomsætning
0.05×
This company
1.12×
Market median
-96% vs market
2020
2024
Gæld/egenkapital
0.73×
This company
0.62×
Market median
+18% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on ImmuneIntelligence AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
